Skip to main content

Table 2 Expression profiles of ISR-miRNAs in healthy controls and acute COVID-19 patients

From: Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response

ISR-miRNAs

Healthy controls (n = 29)

COVID-19 (n = 29)

Z

P

hsa-let-7c-5p

0.22 (0.05, 0.60)

0.21 (0.05, 0.44)

0.00

1.000

hsa-miR-29b-3p

0.06 (0.01, 0.25)

0.33 (0.11, 0.78)

3.15

0.002

hsa-miR-30b-5p

0.28 (0.10, 0.79)

0.58 (0.22, 1.60)

1.59

0.113

hsa-miR-186-5p

0.35 (0.17, 0.94)

0.06 (0.03, 0.19)

3.52

< 0.001

hsa-miR-15a-5p

0.13 (0.04, 0.53)

0.02 (0.01, 0.11)

2.26

0.024

hsa-miR-15b-5p

0.05 (0.02, 0.26)

0.06 (0.02, 0.13)

0.00

1.000

hsa-miR-148a-3p

0.12 (0.02, 0.29)

0.06 (0.03, 0.15)

0.99

0.322

hsa-miR-146b-3p

0.11 (0.03, 0.35)

0.15 (0.07, 0.27)

1.01

0.312

hsa-miR-409-3p

0.11 (0.03, 0.34)

0.24 (0.06, 0.34)

1.23

0.218

hsa-miR-497-5p

0.03 (0.01, 0.11)

0.05 (0.03, 0.12)

0.75

0.456

hsa-miR-548c-5p

0.06 (0.02, 0.28)

0.09 (0.04, 0.28)

1.44

0.151

hsa-miR-1246

0.06 (0.04, 0.11)

0.53 (0.19, 1.12)

4.98

< 0.001